Literature DB >> 1423824

Fatty acid modulation of tumor cell-platelet-vessel wall interaction.

Y Q Chen1, B Liu, D G Tang, K V Honn.   

Abstract

Prostaglandins and other eicosanoids have been studied extensively in their physical, biochemical, biophysical and pharmacological aspects. However, studies on their role in tumor progression, especially metastases are relatively recent. Following a brief overview of the history of discovery and metabolism of eicosanoids and other fatty acids, we discuss the functions of these fatty acids (with emphasis on prostacyclin, thromboxane A2, 12-hydroxyeicosatetraenoic acid and 13-hydroxyoctadecadienoic acid) in cell transformation, tumor promotion and particularly in tumor cell metastasis. The relation between these monohydroxy fatty acids and tumor cell metastasis is discussed from three different perspectives, i.e., their effects on tumor cells, on platelets and on endothelial cells. The mechanism of these effects are then addressed at cell adhesion molecule, motility, protease, cell cytoskeleton, protein kinase and eicosanoid receptor levels. Finally, regulation of three key enzymes which generate eicosanoids (phospholipase, prostaglandin endoperoxide synthase and lipoxygenase) is explored.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1423824     DOI: 10.1007/bf01307189

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  117 in total

1.  High-affinity binding and lack of growth-promoting activity of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) in a human epidermal cell line.

Authors:  E Gross; T Ruzicka; B von Restorff; W Stolz; K N Klotz
Journal:  J Invest Dermatol       Date:  1990-04       Impact factor: 8.551

2.  A new in vitro model for investigation of tumor cell-platelet-endothelial cell interactions and concomitant eicosanoid biosynthesis.

Authors:  D G Menter; B W Steinert; B F Sloane; J D Taylor; K V Honn
Journal:  Cancer Res       Date:  1987-05-01       Impact factor: 12.701

3.  Thromboxanes and prostacyclin: positive and negative modulators of tumor growth.

Authors:  K V Honn; J Meyer
Journal:  Biochem Biophys Res Commun       Date:  1981-10-30       Impact factor: 3.575

4.  Regulation of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) binding sites on human epidermal cells by interferon-gamma.

Authors:  R Süss; P Arenberger; E C Gross; T Ruzicka
Journal:  Exp Cell Res       Date:  1990-12       Impact factor: 3.905

Review 5.  Effects of prostacyclin analogues in in vivo tumor models.

Authors:  M R Schneider; E Schillinger; M Schirner; W Skuballa; S Stürzebecher; W Witt
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1991

6.  Prostaglandin production by normal and transformed 3T3 fibroblasts in cell culture.

Authors:  S Hammarström
Journal:  Eur J Biochem       Date:  1977-03-15

7.  Cicaprost inhibits metastases of animal tumors.

Authors:  M Schirner; M R Schneider
Journal:  Prostaglandins       Date:  1991-11

8.  Tumor cell-platelet interactions in vitro and their relationship to in vivo arrest of hematogenously circulating tumor cells.

Authors:  D G Menter; J S Hatfield; C Harkins; B F Sloane; J D Taylor; J D Crissman; K V Honn
Journal:  Clin Exp Metastasis       Date:  1987 Jan-Mar       Impact factor: 5.150

9.  Prostacyclin/thromboxane ratio in human breast cancer.

Authors:  I B Vergote; P A van Dam; G M Laekeman; G H Keersmaeckers; F L Uyttenbroeck; A G Herman
Journal:  Tumour Biol       Date:  1991

10.  Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.

Authors:  A Masuda; D E Mais; J E Oatis; P V Halushka
Journal:  Biochem Pharmacol       Date:  1991-07-15       Impact factor: 5.858

View more
  10 in total

1.  Prognostic significance of initial platelet counts and fibrinogen level in advanced non-small cell lung cancer.

Authors:  Kyung Hee Kim; Tae Yun Park; Ji Yeun Lee; Sang-Min Lee; Jae-Joon Yim; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Seok-Chul Yang
Journal:  J Korean Med Sci       Date:  2014-04-01       Impact factor: 2.153

2.  Studies on tumor-cell-induced platelet aggregation in human lung cancer cell lines.

Authors:  E Heinmöller; R J Weinel; H H Heidtmann; U Salge; R Seitz; I Schmitz; K M Müller; H Zirngibl
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 3.  12-lipoxygenases and 12(S)-HETE: role in cancer metastasis.

Authors:  K V Honn; D G Tang; X Gao; I A Butovich; B Liu; J Timar; W Hagmann
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

4.  Expression of an ovine growth hormone transgene in mice increases arachidonic acid in cellular membranes.

Authors:  J D Murray; A M Oberbauer; K R Sharp; J B German
Journal:  Transgenic Res       Date:  1994-07       Impact factor: 2.788

5.  Eicosanoids as mediators of linoleic acid-stimulated invasion and type IV collagenase production by a metastatic human breast cancer cell line.

Authors:  X H Liu; J M Connolly; D P Rose
Journal:  Clin Exp Metastasis       Date:  1996-03       Impact factor: 5.150

6.  The preventive effect of ketoconazole on experimental metastasis from a human pancreatic carcinoma may be related to its effect on prostaglandin synthesis.

Authors:  George N Tzanakakis; Elias Krambovitis; Aristidis M Tsatsakis; Michael P Vezeridis
Journal:  Int J Gastrointest Cancer       Date:  2002

7.  Incorporation of polyunsaturated fatty acids into CT-26, a transplantable murine colonic adenocarcinoma.

Authors:  D P Gaposchkin; R A Zoeller; S A Broitman
Journal:  Lipids       Date:  2000-02       Impact factor: 1.646

8.  Inhibition of Collagen-Induced Platelet Aggregation by the Secobutanolide Secolincomolide A from Lindera obtusiloba Blume.

Authors:  Sang-Hyuk Jung; Joo-Hui Han; Hyun-Soo Park; Jung-Jin Lee; Seo Young Yang; Young Ho Kim; Kyung-Sun Heo; Chang-Seon Myung
Journal:  Front Pharmacol       Date:  2017-08-22       Impact factor: 5.810

9.  Platelet-Membrane-Camouflaged Zirconia Nanoparticles Inhibit the Invasion and Metastasis of Hela Cells.

Authors:  Yinghui Shang; Qinghai Wang; Jian Li; Qiangqiang Zhao; Xueyuan Huang; Hang Dong; Haiting Liu; Rong Gui; Xinmin Nie
Journal:  Front Chem       Date:  2020-05-07       Impact factor: 5.221

10.  Novel anti-tumour activity of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4- benzoquinone (CV-6504) against established murine adenocarcinomas (MAC).

Authors:  H J Hussey; M C Bibby; M J Tisdale
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.